Stay updated with breaking news from Genoscreen Deeplex. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The global molecular diagnostic market is slated to commence on an upward trajectory, exhibiting a moderate CAGR of 4.30% from 2024 to 2034. The forecast valuation of US$ 39,611.00 million in 2024 comes from the common thread of influences administering demand for molecular diagnostics. The current projections of DN...
Upcoming Global webinar to bring together leading experts on 22nd May to explain how genomics is changing the TB landscape.
Leveraging NGS-Tech in Healthcare Applications
Expands access to genomic testing and enables personalised medicine for TB patients
/PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and GenoScreen, an innovative genomics company,...